Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sonia Halhol"'
Autor:
Alison Booth, Stephanie Manson, Sonia Halhol, Evie Merinopoulou, Mireia Raluy-Callado, Asha Hareendran, Stefanie Knoll
Publikováno v:
JMIR Cancer, Vol 9, p e45707 (2023)
BackgroundThe treatment of non–small cell lung cancer (NSCLC) has evolved dramatically with the approval of immuno-oncology (IO) and targeted therapies (TTs). Insights on the patient experience with these therapies and their impacts are lacking. He
Externí odkaz:
https://doaj.org/article/8f3ae2fd593d4e3cac2f0c6293dc77ec
Autor:
Guy Faust, Alison Booth, Evie Merinopoulou, Sonia Halhol, Heena Tosar, Amir Nawaz, Magdalena Szlachetka, Gavin Chiu
Publikováno v:
JMIR Cancer, Vol 8, Iss 2, p e34073 (2022)
BackgroundImmunotherapy and targeted therapy treatments are novel treatments available for patients with metastatic and adjuvant melanoma. As recently approved treatments, information surrounding the patients’ and caregivers’ experience with thes
Externí odkaz:
https://doaj.org/article/ab9d53deded646cd890114b020b0e3f9
Autor:
Alison Booth, Stephanie Manson, Sonia Halhol, Evie Merinopoulou, Mireia Raluy Callado, Asha Hareendran, Stefanie Knoll
BACKGROUND The treatment of non–small cell lung cancer (NSCLC) has evolved dramatically with the approval of immuno-oncology (IO) and targeted therapies (TT). Insights on the patient experience with these therapies and their impacts are lacking. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae2709a73d90631de1f13e36b7f7dde
https://doi.org/10.2196/preprints.45707
https://doi.org/10.2196/preprints.45707
Autor:
Guy Faust, Alison Booth, Evie Merinopoulou, Sonia Halhol, Heena Tosar, Amir Nawaz, Magdalena Szlachetka, Gavin Chiu
BACKGROUND Immunotherapy and targeted therapy treatments are novel treatments available for patients with metastatic and adjuvant melanoma. As recently approved treatments, information surrounding the patients’ and caregivers’ experience with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e6dbfff452197deefb65e7fcf1a31d3
https://doi.org/10.2196/preprints.34073
https://doi.org/10.2196/preprints.34073
Autor:
Alison Booth, Timothy Bell, Sonia Halhol, Shiyu Pan, Verna Welch, Evie Merinopoulou, Dimitra Lambrelli, Andrew Cox
BACKGROUND Until recently, treatment options were limited for patients with acute myeloid leukemia and myelodysplastic syndrome (AML and MDS) who are ineligible for intensive chemotherapy. Owing to the condition’s rapid progression, it is difficult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e25741e4c82525be57ee5cdd84f50b3
https://doi.org/10.2196/preprints.14285
https://doi.org/10.2196/preprints.14285
Autor:
E. Merinopoulou, Andrew Cox, Alison Booth, Dimitra Lambrelli, Shiyu Pan, Verna L Welch, Timothy J Bell, Sonia Halhol
Publikováno v:
Journal of Medical Internet Research
Background Until recently, treatment options were limited for patients with acute myeloid leukemia and myelodysplastic syndrome (AML and MDS) who are ineligible for intensive chemotherapy. Owing to the condition’s rapid progression, it is difficult
Autor:
Andrew G. Cox, Timothy J Bell, Sonia Halhol, Verna L Welch, E. Merinopoulou, Alison Booth, Shiyu Pan, Dimitra Lambrelli
Publikováno v:
Blood. 132:4826-4826
Objectives: Treatment options for patients with AML/MDS who are ineligible for intensive chemotherapy are limited. Due to rapid progression of the condition it is difficult to capture what is most important to patients when making treatment decisions
Autor:
Timothy J Bell, E. Merinopoulou, Shiyu Pan, Sonia Halhol, Verna L Welch, Alison Booth, Andrew G. Cox, Dimitra Lambrelli
Publikováno v:
Blood. 132:4831-4831
Objectives: For patients with AML/MDS who are ineligible for intensive chemotherapy, prognosis is poor and effective treatment options are limited, often leading to unmet medical needs in this population. A deeper understanding of the patient perspec